ArticleFrontiers in oncology2026
Prognostic significance of NTMT1 and its association with tumor progression in oral squamous cell carcinoma.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Oral squamous cell carcinoma (OSCC) is a common malignant tumor of the oral cavity that significantly impacts patients' quality of life and presents substantial economic challenges due to its high incidence and mortality. Methods: Weighted gene co-expression network analysis and differential expression gene screening were applied to identify key genes involved in OSCC progression. The expression of NTMT1 in OSCC was examined using The Cancer Genome Atlas database and the Human Protein Atlas database. One-way analysis of variance was used to compare NTMT1 expression among patients with different pathological statuses. Kaplan-Meier survival analysis and Cox regression analysis were performed to investigate the relationship between NTMT1 and prognosis. Gene Ontology analysis and gene set enrichment analysis (GSEA) were conducted to explore the functions and pathways of NTMT1. The correlations between NTMT1 expression and m6A-related genes as well as immune cells were analyzed using R software. Additionally, Results: NTMT1 was found to be upregulated in OSCC tissues, with higher expression correlating with poorer survival outcomes. Statistical analyses demonstrated significant associations between NTMT1 expression and various clinicopathological characteristics, including pathologic stage and lymphovascular invasion. Univariate Cox regression analysis indicated NTMT1 as a significant risk factor for OSCC, although multivariate analysis did not confirm its independent prognostic value. Functional analysis revealed NTMT1-associated genes involved in lipid transport, cell adhesion, and DNA repair. GSEA highlighted pathways such as cell cycle checkpoints and Notch signaling. Additionally, NTMT1 expression was positively correlated with m6A methylation-related genes and specific immune cell infiltrations. NTMT1 overexpression promoted the proliferation, migration and invasion of OSCC cells. Conclusion: NTMT1 might play a crucial role in OSCC progression and have the potential to serve as a biomarker for prognosis and therapeutic targeting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.